wedge
BIOTROFIX - Premier Preclinical CRO
BIOTROFIX - Premier Preclinical CRO BIOTROFIX - Premier Preclinical CRO - Stroke, Alzheimer's, ALS, TBI Research - Seth P. Finklestein, M.D., CEO BIOTROFIX - Premier Preclinical CRO A Premier Preclinical CRO Specializing in Models of CNS and Vascular Disease BIOTROFIX - Premier Preclinical CRO
BIOTROFIX - Premier Preclinical CRO BIOTROFIX - Premier Preclinical CRO BIOTROFIX - Premier Preclinical CRO BIOTROFIX - Premier Preclinical CRO BIOTROFIX - Premier Preclinical CRO
 
Home
greybar
The Company
greybar
Preclinical Research Services
PK/PD Studies
Acute Stroke
Stroke Recovery
Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Traumatic Brain Injury
Spinal Cord Injury
Muscular Dystrophy
Myocardial Infarction
Peripheral Vascular Disease
Others
Will Travel Services
greybar
The Team
greybar
News from Biotrofix
greybar
Publications
greybar
Contact Us


small animal surgery, drug delivery, and animal behavior assessment methods
 

Preclinical Research Services, drug development, cardiac disease, drug discovery - Seth P. Finklestein M.D.

Sitemap of Biotrofix

 
 
Home | The Company | Preclinical Research Services | The Team | News | Publications | Contact Us | Site Map
wedgeBiotrofix, Inc. 604 Webster Street, Needham, MA 02494 Tel: 781-786-8890 Fax: 781-465-6061


Biotrofix is a premier preclinical contract research organization specializing in animal models of CNS, cardiac and vascular disease. With years of experience, both academic, commercial, clients throughout the biotech and pharmaceutical industries, Biotrofix delivers industry-leading preclinical CRO services, including rodent models of acute stroke and stroke recovery, preclinical CRO services for Alzheimer's Disease, transgenic animal models for ALS, as well as CRO services for brain injury, preclinical CRO services for spinal cord injury and related cardiac drug discovery and development.